What is the recommended ibuprofen (nonsteroidal anti-inflammatory drug, NSAID) dose per kilogram for a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ibuprofen should be used with caution in newborns and the recommended dose is 2 mg/kg for infants less than 6 months of age, as stated in the study published in Pediatrics in 2008 1. When considering the use of ibuprofen in newborns, it is essential to weigh the potential benefits against the risks, including immature kidney function, increased risk of gastrointestinal bleeding, and potential adverse effects on the developing cardiovascular system. Key points to consider when administering ibuprofen to newborns include:

  • The dose of 2 mg/kg for infants less than 6 months of age, as recommended in the study 1
  • The potential risks and side effects, such as gastrointestinal bleeding and adverse effects on the developing cardiovascular system
  • The importance of consulting with a pediatrician before administering any medication to a newborn, as they will provide guidance based on the specific clinical situation and the infant's health status In specific medical circumstances, such as patent ductus arteriosus closure in premature infants, ibuprofen may be used under strict specialist supervision at specific doses, but this is a specialized hospital-based treatment not meant for routine use. The use of ibuprofen in newborns requires careful consideration of the potential risks and benefits, and should only be done under the guidance of a pediatrician, taking into account the specific clinical situation and the infant's health status, as supported by the study published in Pediatrics in 2008 1.

From the Research

Ibuprofen Dosage for Newborns

  • The dosage of ibuprofen for newborns, specifically for the treatment of patent ductus arteriosus (PDA), has been studied in various clinical trials 2, 3, 4, 5, 6.
  • According to a study published in 2004, newborns were randomized to receive ibuprofen or placebo for the prophylactic treatment of PDA at an initial dose of 10 mg/kg ibuprofen within 6 hours after birth, followed by two 5-mg/kg doses at 24-hour intervals 2.
  • Another study published in 2018 suggested that a first dose of 20 mg/kg followed by 10 mg/kg every 24 hours is effective, but also proposed an alternative dosing regimen of 18 mg/kg as the first dose, followed by 4 mg/kg every 12 hours, with an increase to 5 mg/kg every 12 hours after 96 hours postnatal age 3.
  • A systematic review published in 2006 recommended a starting dose of 10 mg/kg followed by 5 mg/kg/d for 2 more days for optimal efficacy with the least adverse effects 4.
  • A study published in 2012 compared oral and intravenous ibuprofen and found that both forms are effective, but oral ibuprofen may have a higher incidence of sepsis and bronchopulmonary dysplasia 5.
  • A Cochrane review published in 2013 found that ibuprofen is as effective as indomethacin in closing a PDA and reduces the risk of necrotizing enterocolitis (NEC) and transient renal insufficiency 6.

Dosage Recommendations

  • Initial dose: 10 mg/kg ibuprofen within 6 hours after birth 2
  • Alternative initial dose: 20 mg/kg followed by 10 mg/kg every 24 hours 3
  • Proposed alternative dosing regimen: 18 mg/kg as the first dose, followed by 4 mg/kg every 12 hours, with an increase to 5 mg/kg every 12 hours after 96 hours postnatal age 3
  • Recommended dosing regimen: 10 mg/kg followed by 5 mg/kg/d for 2 more days 4

Related Questions

Can I give ibuprofen to a 26-week preterm infant with impaired renal function due to severe hydronephrosis and constipation for pain management, as Tylenol (acetaminophen) is insufficient?
Is the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as indomethacin or ibuprofen recommended for promoting ductal closure in cases of patent ductus arteriosus (PDA) diagnosed in utero?
What are the guidelines for antibiotic therapy before and after surgical treatment of an infected sebaceous cyst, including first-line and alternative antibiotics, and their recommended course durations?
What is the recommended next step for a 69-year-old man with postoperative acute kidney injury (Impaired renal function), hyperkalemia, and metabolic acidosis, who has been experiencing severe pain and somnolence following surgical repair of a tibial plateau fracture, and has received Patient-Controlled Analgesia (PCA) hydromorphone, anti-nausea medications, and a bowel regimen, with a history of hypertension, obesity, and sleep apnea, currently presenting with oliguria and mild abdominal tenderness?
What is Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?
What is the next diagnostic test to order for a 32-year-old man with dyspnea (shortness of breath), hemoptysis (coughing up blood), fever, fatigue, and abdominal pain, who has a history of hypertension treated with hydralazine, and recently diagnosed asthma treated with albuterol (albuterol) inhaler and oral corticosteroids, presenting with tachycardia (rapid heart rate), tachypnea (rapid breathing), mild hypoxemia (low oxygen levels), nasal crusting, bilateral wheezing and rhonchi, anemia (low hemoglobin), leukocytosis (high white blood cell count), lymphocytosis (high lymphocyte count), eosinophilia (high eosinophil count), and impaired renal function (elevated creatinine), with radiographic findings of patchy bilateral opacities, centrilobular nodules, bronchial wall thickening, and subpleural consolidations?
What are the recommended sedation medications for patients with dementia?
How does Substance P (Substance Peptide) cause nausea?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.